Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies

Anna Patrikidou, Isabelle Sinapi, Hélène Regnault, Florence Fayard, Mohamed Bouattour, Laetitia Fartoux, Sandrine Faivre, David Malka, Michel Ducreux, Valerie Boige
  • Investigational New Drugs, April 2014, Springer Science + Business Media
  • DOI: 10.1007/s10637-014-0100-y
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Mohamed Bouattour